Growth-hormone secretagogue research peptide for controlled laboratory studies.
- Dose
- 10 mg
- Batch
- 268009
Ipamorelin
2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
For research purposes only — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Growth-hormone secretagogue research peptide for controlled laboratory studies.
Members get 10% off every order, on top of volume pricing — become a member with a free account.
Volume savings are applied automatically at checkout. Larger orders: support@alptide.at
- Lab
- Janoshik Analytical
- Purity
- 99.665%
- Methods
- HPLC · LC-MS
- Tested
- Oct 6, 2026
For laboratory research use only. Not for human consumption.
Technical specifications
- Type
- Peptide
- Scientific name
- 2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
- Amino acids
- 5
- Molecular weight
- 711.9 g/mol
- Formula
- C38H49N9O5
- CAS
- 170851-70-4
- Origin
- Synthetic pentapeptide GHS-R1a agonist developed at Novo Nordisk as NNC 26-0161; residue sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 contains non-proteinogenic residues, so it has no valid one-letter code.
- Lyophilized (powder)
- -20°C, protected from light and moisture · stable long-term; -80°C for multi-year storage
- Reconstituted
- 2-8°C in sterile bacteriostatic or acetate buffer · use within 30 days; aliquot to avoid repeated freeze-thaw cycles
- Room temperature
- Lyophilized powder tolerates brief ambient excursions during shipping, but sustained room-temperature storage is not appropriate — the C-terminal lysinamide and the His residue make the peptide susceptible to hydrolysis and oxidation, and reconstituted solutions left at room temperature degrade within days.
Peer-reviewed research
Published research and registered trials involving this compound. Provided for educational reference only — none of it is a claim about this product.
- European Journal of EndocrinologyIpamorelin, the first selective growth hormone secretagogueRaun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH1998DOI: 10.1530/eje.0.1390552PMID: 9849822
- XenobioticaPharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorptionJohansen PB, Hansen KT, Andersen JV, Johansen NL1998DOI: 10.1080/004982598238976PMID: 9879640
- Growth Hormone & IGF ResearchIpamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsJohansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H1999DOI: 10.1054/ghir.1999.9998PMID: 10373343
- Pharmaceutical ResearchPharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteersGobburu JV, Agersø H, Jusko WJ, Ynddal L1999DOI: 10.1023/a:1018955126402PMID: 10496658
- Journal of Pharmacology and Experimental TherapeuticsEfficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileusVenkova K, Mann W, Nelson R, Greenwood-Van Meerveld B2009DOI: 10.1124/jpet.108.149211PMID: 19289567
- International Journal of Colorectal DiseaseProspective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patientsBeck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group2014DOI: 10.1007/s00384-014-2030-8PMID: 25331030
Researcher reviews
“Reconstituted clean with no cloudiness, and the batch ID on the label matched the certificate every time. Three orders now, no surprises.”
More in GH Secretagogues
CJC-1295 (No DAC)
10 mg / vial
Growth-hormone secretagogue research peptide for controlled laboratory studies.
Tesamorelin
10 mg / vial
Growth-hormone-releasing-hormone analogue for controlled laboratory research.